| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $966.70M |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B |
| Operating Expenses | – | – | – | – | – |
| R&D | $172.20M | $155.10M | $137.40M | $110.30M | $92.70M |
| SG&A | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B |
| Operating Income | $682.90M | $705.70M | $533.10M | $507.60M | $505.80M |
| Interest Expense | – | – | $105.30M | $57.30M | $23.10M |
| Tax Expense | $191.60M | $190.00M | $118.70M | $89.50M | -$2.45B |
| Net Income | $374.90M | $392.30M | $294.20M | $385.80M | $2.94B |
| EPS (basic) | 1.8800 | 1.9700 | 5.9400 | 7.8300 | 59.8000 |
| EPS (diluted) | 1.8700 | 1.9600 | 5.9100 | 7.7600 | 59.1600 |
| Shares (diluted) | $200.00M | $200.40M | $49.80M | $49.70M | $49.80M |